Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lock

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Epilepsia|October 20, 2020
Fenfluramine HCl (Fintepla<sup>®</sup> ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension studyJoseph Sullivan, Ingrid E Scheffer, Lieven Lagae, et al.
Annals of Palliative Medicine|November 12, 2023
Treatment modalities to manage hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and meta-analysisBrandon Liu, Natalie Grindrod, Brandon M Meyers, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastasesGeorge Rodrigues, Slav Yartsev, Brian Yaremko, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2011
Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lipMichael Lock, Jeffrey Q Cao, David P D'Souza, et al.
Technology in Cancer Research & Treatment|September 20, 2006
Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapyJames S Welsh, Michael Lock, Paul M Harari, et al.
The Lancet. Infectious Diseases|February 2, 2013
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyMarc Gurwith, Michael Lock, Eve M Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
Journal of Nuclear Medicine Technology|May 16, 2023
PET/MRI Assessment of Acute Cardiac Inflammation 1 Month After Left-Sided Breast Cancer Radiation TherapyOi Wai Chau, Ali Islam, Michael Lock, et al.
European Urology Oncology|January 4, 2026
Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|August 26, 2019
Symptom clusters in patients with breast cancer receiving radiation therapySelina Chow, Bo Angela Wan, William Pidduck, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Epilepsia|October 20, 2020
Fenfluramine HCl (Fintepla<sup>®</sup> ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension studyJoseph Sullivan, Ingrid E Scheffer, Lieven Lagae, et al.
Annals of Palliative Medicine|November 12, 2023
Treatment modalities to manage hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and meta-analysisBrandon Liu, Natalie Grindrod, Brandon M Meyers, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastasesGeorge Rodrigues, Slav Yartsev, Brian Yaremko, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2011
Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lipMichael Lock, Jeffrey Q Cao, David P D'Souza, et al.
Technology in Cancer Research & Treatment|September 20, 2006
Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapyJames S Welsh, Michael Lock, Paul M Harari, et al.
The Lancet. Infectious Diseases|February 2, 2013
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyMarc Gurwith, Michael Lock, Eve M Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
Journal of Nuclear Medicine Technology|May 16, 2023
PET/MRI Assessment of Acute Cardiac Inflammation 1 Month After Left-Sided Breast Cancer Radiation TherapyOi Wai Chau, Ali Islam, Michael Lock, et al.
European Urology Oncology|January 4, 2026
Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical TrialLucas C Mendez, Juanita Crook, Kevin Martell, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|August 26, 2019
Symptom clusters in patients with breast cancer receiving radiation therapySelina Chow, Bo Angela Wan, William Pidduck, et al.
Pageof 17